Preliminary Indications from SoftPAP®
Collector Clinical Trial Very Promising, Showing Statistically
Significant Reduction in False Positives
Revenues up 100%...
CytoCore Inc. (OTCBB:CYOE), the developer of cost-effective, highly
accurate screening systems for early detection of gynecological cancers
and sexually transmitted diseases, today...
CytoCore Names President, International Operations
CytoCore Inc. (OTCBB:CYOE), the biopharmaceutical research and medical
device company for early detection and treatment of...
CEO Dr. Floyd Taub Highlights Latest Innovations and Practices in Upcoming Issue
CytoCore Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and...
CHICAGO--(BUSINESS WIRE)--July 24, 2006--CytoCore,Inc. (OTCBB:MCDG), a biomolecular diagnostics screening company committed to bringing new cancer solutions to the market, has announced the...
CHICAGO--(BUSINESS WIRE)--July 18, 2006--CytoCore, Inc. (OTCBB: MCDG) announced that CEO David Weissberg was interviewed by The Wall Street Reporter this past week. Dr. Weissberg discussed...
CHICAGO--(BUSINESS WIRE)--July 17, 2006--CytoCore, Inc. (OTCBB:MCDG) announced that it has engaged Beaufort Advisors as its FDA regulatory consultants. CytoCore's CEO David Weissberg stated: "We...
#20: MCDG News CytoCore Retains MMI Associates, Inc.; Raleigh PR Firm To Provide Public Relations And Product Marketing Services To Uterine And Cervical Cancer Screening Firm
CHICAGO--(BUSINESS WIRE)--July 6, 2006--CytoCore, Inc. (OTCBB:MCDG), a biomolecular diagnostics screening company has announced that the firm has signed an agreement with MMI Associates, Inc. for...
CHICAGO--(BUSINESS WIRE)--June 28, 2006--CytoCore, Inc. (OTCBB:MCDG) announced that its CEO, David Weissberg, and CFO, Robert McCullough Jr., will represent the Company at JP Turners annual...
CHICAGO--(BUSINESS WIRE)--June 22, 2006--CytoCore, Inc. (OTCBB:MCDG) announced the following results from their annual shareholders meeting held on Friday June 16th. First, shareholders voted to...
CHICAGO--(BUSINESS WIRE)--Dec. 22, 2005--Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: MOLECULAR CHANGES ITS NAME TO...
CHICAGO--(BUSINESS WIRE)--Oct. 26, 2005--Molecular Diagnostics, Inc. (OTCBB: MCDG.OB) filed suit on Friday, October 21, 2005 against Diamics, Inc. and Diamics LLC. for unfair business practices,...
CHICAGO--(BUSINESS WIRE)--Oct. 11, 2005--The head of Molecular Diagnostics, Inc. (OTCBB: MCDG.OB) Medical Advisory committee, Dr. George Gorodeski, M.D., Ph.D., Professor, Department of...
CHICAGO--(BUSINESS WIRE)--Oct. 7, 2005--Molecular Diagnostics, Inc. (OTCBB: MCDG.OB) announces that CEO David Weissberg will be interviewed on CEOcast today, Friday October 7th. The interview can...